Format

Send to

Choose Destination
Pharmacol Biochem Behav. 1993 Oct;46(2):453-7.

Nicotine and brain-stimulation reward: interactions with morphine, amphetamine and pimozide.

Author information

1
Laboratory of Behavioral Pharmacology, Boston University School of Medicine, MA 02118.

Abstract

Using a rate-independent discrete trial method of determining thresholds for rewarding electrical intracranial stimulation in rats, we evaluated the pharmacological interaction of nicotine plus morphine, d-amphetamine, or the D2 receptor antagonist, pimozide. Both morphine and amphetamine shifted the dose-response curve for nicotine down and to the left, indicating increased efficacy and potency, respectively. Pimozide at doses that have no effect on performance and only minimal effect on brain-stimulation reward blocked the effect of nicotine. These data suggest that the same dopaminergic substrate that supports the positive reinforcing effects of other drugs of abuse also supports nicotine reward.

PMID:
8265701
DOI:
10.1016/0091-3057(93)90378-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center